AzTrials
AzTrials

HealthyNCT03788356

Acute Effects of Inspiratory Muscle Training at Different Intensities in Healthy People

A study testing Inspiratory muscle training and Diaphragmatic breathing in people with Healthy, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

At least 30 volunteers will be included in the study. After questioning the demographic and clinical information of the participants, dyspnea perception, respiratory functions, respiratory muscle strength, heart rate variability, arterial stiffness, and blood pressure and physical activity levels will be evaluated. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Inspiratory muscle training and Diaphragmatic breathing
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Jan 2019to 4 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy People

Who cannot join

  • Body mass index (BMI) > 30 kg/m²
  • Smoking
  • The presence of exercise habit
  • Medication use
  • Neurological, cardiovascular or respiratory disorders

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Dokuz Eylül University

    Izmir, 35320

Other trials in Turkey (Türkiye)

About this study

At least 30 volunteers will be included in the study. After questioning the demographic and clinical information of the participants, dyspnea perception, respiratory functions, respiratory muscle strength, heart rate variability, arterial stiffness, and blood pressure and physical activity levels will be evaluated. Inspiratory muscle training will be done for 15 minutes with an electronic device. Respiratory training will be applied at three different concentrations with 10%, 30% and 60% of maximal inspiratory pressure. Heart rate variability, arterial stiffness, and blood pressure measurements will be repeated after inspiratory muscle training sessions at different intensities.

Read the detailed description

Cardiovascular diseases are the leading cause of mortality in developed and developing countries and constitute a significant morbidity burden for life. Cardiovascular diseases risk factors include obesity, lipid profile, unhealthy diet, sedentary lifestyle, high blood pressure, increased arteriosclerosis.

Although aerobic exercise is recommended as exercise modality to reduce cardiovascular risk, the effects of resistant exercise on cardiovascular health are not clear. In addition, regular aerobic and resistant exercise regulate cardiac autonomic function.

Inspiratory muscle training is a time-efficient, well-tolerated and safe approach for both healthy people and people with chronic diseases. Long-term inspiratory muscle training has been shown to increase respiratory muscle strength and decrease blood pressure in healthy individuals. One-session inspiratory muscle training has been shown to improve autonomic function in smokers and older individuals. However, the effects of different intensities of inspiratory muscle training on blood pressure, autonomic function, and arterial stiffness in healthy young people are not fully understood. For these reasons, the aim of the study is to investigate the acute effects of inspiratory muscle training at different intensities in healthy people.

At least 30 volunteers will be included in the study. After questioning the demographic and clinical information of the participants, dyspnea perception, respiratory functions, respiratory muscle strength, heart rate variability, arterial stiffness, and blood pressure and physical activity levels will be evaluated. Inspiratory muscle training will be done for 15 minutes with an electronic device. Respiratory training will be applied at three different concentrations with 10%, 30% and 60% of maximal inspiratory pressure. Heart rate variability, arterial stiffness, and blood pressure measurements will be repeated after inspiratory muscle training sessions at different intensities.

Conditions
Healthy
Being tested
Inspiratory muscle training, Diaphragmatic breathing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inspiratory muscle trainingDevice

    Inspiratory muscle training with a device

  • Diaphragmatic breathingOther

    Also called Exercise

    Diaphragmatic breathing exercise

Study groups in NCT03788356
Study groupRoleWhat they receive
Diaphragmatic breathingExperimentalDiaphragmatic breathing exercise for 15 minutes.
Receives: Other: Diaphragmatic breathing
10% inspiratory muscle trainingExperimentalInspiratory muscle training at 10% intensity of maximal inspiratory pressure for 15 minutes
Receives: Device: Inspiratory muscle training
30% inspiratory muscle trainingExperimentalInspiratory muscle training at 30% intensity of maximal inspiratory pressure for 15 minutes
Receives: Device: Inspiratory muscle training
60% inspiratory muscle trainingExperimentalInspiratory muscle training at 60% intensity of maximal inspiratory pressure for 15 minutes
Receives: Device: Inspiratory muscle training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart Rate

    The heart rate is the number of beats per minute of the heart. It represents both sympathetic and parasympathetic system activity. increased heart rate indicates that the sympathetic activity is dominant, while decreased heart rate indicates that parasympathetic activity is dominant.

    Measured: Change from Baseline at 15 minutes

  2. Augmentation Index

    Augmentation index is commonly used noninvasive measurements of wave reflection strength. To assess augmentation index, brachial artery compression waveforms were obtained by partially inflating a cuff over the brachial artery approximately midway between the shoulder and the elbow. The brachial waveforms were calibrated using cuff-measured brachial systolic and diastolic pressures, and then used to generate central aortic pressure waveforms by applying proprietary digital signal processing and transfer function. The central aortic pulse wave was used to determine augmentation index. High values represent abnormal wave reflection strength.

    Measured: Change from Baseline at 15 minutes

  3. Aortic Pulse Wave Velocity

    Aortic pulse wave velocity is commonly used noninvasive measurements of arterial stiffness. To assess aortic pulse wave velocity, carotid pulse waves were measured by applanation tonometry and femoral pulse waves were simultaneously obtained by a partially inflated cuff over the femoral artery at the leg midway between the hip and the knee. Aortic pulse wave velocity was determined by calculating the ratio of the corrected distance between the pulse measuring sites to the time delay between the carotid and femoral pulse waves. High values represent increased arterial stiffness.

    Measured: Change from Baseline at 15 minutes

  4. Square Root of The Mean Squared Difference of Successive Normal to Normal R-R Intervals

    Square Root of The Mean Squared Difference of Successive Normal to Normal R-R Intervals is one of the time domain methods of heart rate variability. It represents a primarily parasympathetic activity or vagal modulation. Low values indicate decreased parasympathetic activity. High values indicate increased parasympathetic activity.

    Measured: Change from Baseline at 15 minutes

Secondary outcomes (16)
  1. Maximal inspiratory pressure

    Assessment of maximal inspiratory pressure with an electronic mouth pressure device (Micro; Micro Medical Ltd., Rochester, UK). Higher values indicate stronger inspiratory muscle strength.

    Measured: At Baseline

  2. Maximal expiratory pressure

    Assessment of maximal expiratory pressure with an electronic mouth pressure device (Micro; Micro Medical Ltd., Rochester, UK). Higher values indicate stronger expiratory muscle strength.

    Measured: At Baseline

  3. Blood pressure

    Brachial and central systolic and diastolic blood pressure. High Brachial and central systolic and diastolic blood pressure are associated with higher risk of heart attacks and strokes, even in people with normal cuff Blood pressure.

    Measured: Change from Baseline at 15 minutes

  4. Forced vital capacity

    Forced vital capacity is defined as the amount of air that can be forcibly exhaled from the lungs after taking the deepest breath possible.

    Measured: At Baseline

  5. Vital capacity

    The vital capacity is the volume of air a subject is able to expire after a maximal inspiration to the total lung capacity.

    Measured: At Baseline

  6. Forced expiratory volume in 1 second

    The volume of air expired in the first second of expiration or forced expiratory volume in 1 second, especially when expressed as a ratio with the total amount of air expired during the forced vital capacity, is a good index of expiratory airways resistance.

    Measured: At Baseline

  7. International Physical Activity Questionnaire

    The International Physical Activity Questionnaire short-form measures physical activity. The International Physical Activity Questionnaire short-form occurs 7 items. The higher values indicate better physical activity level. The minimum score of scale was 0, and maximum score is depend on patients activity and there is no maximum score.

    Measured: At Baseline

  8. Fatigue level

    Fatigue level after the training will be questioned with a 100-mm visual analog scale, minimum 0 to maximum 100. Higher scores indicate higher fatigue levels.

    Measured: Change from Baseline at 15 minutes

  9. Dyspnea level

    Dyspnea level after the training will be questioned with the modified Borg Scale. Minimum value is 0 (no dyspnea), and maximum value is 10 (maximal dyspnea) Higher scores indicate higher fatigue levels.

    Measured: Change from Baseline at 15 minutes

  10. Percentage Of Successive N-N Intervals With A Difference of Duration Longer Than 50 ms

    Square Root of The Mean Squared Difference of Successive Normal to Normal R-R Intervals is one of the time domain methods of heart rate variability. It represents parasympathetic activity. Low values indicate decreased parasympathetic activity. High values indicate increased parasympathetic activity.

    Measured: Change from Baseline at 15 minutes

  11. Low Frequency Power

    Low Frequency is one of the frequency domain methods of heart rate variability. Spectral power analysis is performed on a series of R-R intervals which separates the heart rate spectrum into various components and allows the quantification of sympathetic and vagal influences on the heart. Low Frequency range is 0.04-0.15 Hz. Low frequency band represents both sympathetic and parasympathetic modulation.

    Measured: Change from Baseline at 15 minutes

  12. High Frequency Power

    High Frequency is one of the frequency domain methods of heart rate variability. Spectral power analysis is performed on a series of R-R intervals which separates the heart rate spectrum into various components and allows the quantification of sympathetic and vagal influences on the heart. High Frequency range is 0.15-0.4 Hz. High Frequency band represents parasympathetic modulation. Low values indicate decreased parasympathetic activity. High values indicate increased parasympathetic activity.

    Measured: Change from Baseline at 15 minutes

  13. Low Frequency/High Frequency ratio

    Low Frequency/High Frequency ratio is one of the frequency domain methods of heart rate variability. Low Frequency/High Frequency ratio is a index of sympathovagal balance. Increased ratio indicates that the sympathetic activity is dominant, while decreased ratio indicates that parasympathetic activity is dominant.

    Measured: Change from Baseline at 15 minutes

  14. Total Power

    Total Power is one of the frequency domain methods of heart rate variability. It shows general change of autonomic modulation. Low values indicate decreased autonomic modulation. High values indicate increased autonomic modulation.

    Measured: Change from Baseline at 15 minutes

  15. Pulse Transit Time

    Pulse transit time is the time that takes the pulse pressure wave to travel through the arterial tree. Decreased pulse transit time shows increased wave velocity on the vessels.

    Measured: Change from Baseline at 15 minutes

  16. Standard Deviation of Normal to Normal R-R Intervals

    Standard Deviation of Normal to Normal R-R Intervals is one of the time domain methods of heart rate variability. Time Domain Analysis measures the change in heart rate over time or the intervals between successive normal cardiac cycles.It assesses globally heart rate variability. Low values indicate decreased heart rate variability. High values indicate increased heart rate variability.

    Measured: Change from Baseline at 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2018
  2. Study start2 Jan 2019
  3. Primary completion4 Apr 2019
  4. Study completion4 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03788356
Sponsor's protocol ID
2018/14-16
Status last verified
Apr 2019
First submitted
18 Dec 2018
Last updated
8 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Tanriverdi A, Kahraman BO, Ozsoy I, Ozpelit E, Savci S. Acute effects of inspiratory muscle training at different intensities in healthy young people. Ir J Med Sci. 2021 May;190(2):577-585. doi: 10.1007/s11845-020-02353-w. Epub 2020 Aug 26.

    PubMed 32851483

Questions about this trial

What is this clinical trial studying?

A study testing Inspiratory muscle training and Diaphragmatic breathing in people with Healthy, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart Rate (time frame: Change from Baseline at 15 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03788356, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in